Eno Active Fruit Salt Regular 5.0g Powder

As an antacid: e.g. for the fast relief of indigestion and heartburn.

As a urinary alkaliniser

As an antacid:

ADULTS: One 5 ml medicine measure or one sachet in a glass of water. A second dose may be taken after 2-3 hours. Minimum dosing interval: 2 hours Maximum daily dose (MDD): 2 x 5 ml medicine measures or 2 sachets. Maximum duration of antacid use at MDD: 14 days.

As a urinary alkaliniser:

ADULTS: One 5 ml medicine measure or one sachet well diluted with water to be taken after meals morning and evening.

Hypersensitivity to any of the ingredients of ENO ACTIVE FRUIT SALTS, including excipients. Avoid use if suffering from hypertension, heart failure or cirrhosis of the liver and in patients with impaired hepatic and renal failure. ENO ACTIVE FRUIT SALTS should not be administered to patients with metabolic or respiratory alkalosis, hypocalcaemia or hypochlorhydria. Should not be given with urinary antiseptics which require an acid urine, such as methenamine mandelate and methenamine hippurate.

Use with care in patients suffering from oedema and renal insufficiency. ENO ACTIVE FRUIT SALTS does not eradicate bacteriuria, although they may temporarily relieve lower urinary tract symptoms. Do not use in patients with congestive heart failure or hypertension except under the advice and supervision of a doctor. Not to be used excessively. If there is persistent discomfort, a doctor should be consulted.

Citric acid ingested frequently or in large quantities may cause erosion of the teeth and local irritation. Excessive doses may lead to sodium overloading and hyperosmolality. Contains sodium. Persons on a sodium-restricted diet should not take multiple doses of ENO ACTIVE FRUIT SALTS unless directed by a doctor. Excessive administration may lead to metabolic alkalosis especially in patients with impaired renal function.

ENO ACTIVE FRUIT SALTS may interact with many medicines, affecting the rate and/or extent of their absorption. Sodium bicarbonate administration leads to alkalinisation of the urine resulting in increased renal clearance of acidic medicines, or decreased renal clearance of basic medicines which may result in toxicity. Sodium bicarbonate enhances lithium excretion.

Safety in pregnancy and lactation has not been established.

No significant effect on the ability to perform task that require judgement, motor, or cognitive skills.

Frequencies of the following side effects are unknown.

Gastrointestinal disorders: Flatulence, stomach cramps, abdominal distension. Citric acid ingested frequently or in large quantities may cause erosion of the teeth and local irritation. Not to be used excessively. If there is persistent discomfort, consult a doctor.

Metabolic disorders: Excessive administration may lead to metabolic alkalosis especially in patients with impaired renal function. Symptoms may include shortness of breath, muscle weakness and mental disturbances such as restlessness, convulsions and coma. Muscle hypertonicity, twitching and tetany may develop especially in hypocalcaemic patients. (See WARNINGS AND SPECIAL PRECAUTIONS)

See SIDE EFFECTS Excessive administration of sodium bicarbonate may lead to metabolic alkalosis. Treatment is supportive and symptomatic and consists mainly of correction of fluid and electrolyte balance. A doctor should be consulted in known cases of overdosage.